FDA NDC Directory · JSON-LD · Markdown

AMONDYS 45

NDC 60923-227 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namecasimersen
Labeler / ManufacturerSarepta Therapeutics, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA213026
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsCASIMERSEN (50 mg/mL)
Marketing started20210225
Package count1

External sources

Source: openFDA. Public-domain (CC0).